ONEMEDNET CORPORATION Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount
ONEMEDNET CORPORATION (ONMD) reported Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount of $800.00 thousand for the 12-month period ending 2025-12-31, per its S-1/A filed 2026-07-08.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets
us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount · last filed 2026-07-08
- ONEMEDNET CORPORATION valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2024 was $1.80M, a 50.00% increase from fiscal 2023.
- ONEMEDNET CORPORATION valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2023 was $1.20M, a 13.31% decline from fiscal 2022.
- ONEMEDNET CORPORATION valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2022 was $1.38M.
| Period end | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 11 month | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month as first filed |
|---|---|---|---|
| 2025-12-31 | $800.00K S-1/A · filed 2026-07-08 | ||
| 2024-12-31 | $1.80M 10-K · filed 2025-04-15 | ||
| 2023-12-31 | $1.20M 10-K/A · filed 2024-11-05 | $351.73K 10-K · filed 2024-04-09 | |
| 2022-12-31 | $1.38M 10-K · filed 2024-04-09 | $715.35K 10-K · filed 2023-03-31 | |
| 2021-12-31 | $118.53K 10-K · filed 2023-03-31 | $764.88K 10-Q · filed 2023-11-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |